Male breast cancer: Pathological and immunohistochemical features

被引:0
|
作者
Willsher, PC
Leach, LH
Ellis, IO
Bell, JA
Elston, CW
Bourke, JB
Blamey, RW
Robertson, JFR
机构
[1] CITY HOSP,PROFESSORIAL SURG UNIT,NOTTINGHAM NG5 1PB,ENGLAND
[2] CITY HOSP,DEPT HISTOPATHOL,NOTTINGHAM NG5 1PB,ENGLAND
[3] UNIV NOTTINGHAM HOSP,DEPT SURG,NOTTINGHAM NG7 2UH,ENGLAND
关键词
male breast cancer; pathology; immunohistochemistry;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are infrequently reported. Materials and Methods. We investigated the biological characteristics of forty-one male patients with invasive breast cancer by assessing histopathological and multiple immunohistochemical features. Results. The majority wets no special type (ductal) (37/41), lobular cancer was not seen. 73% were histological grade 3, 93% were positive for oestrogen receptor and 73% for progesterone receptor. The proportion of cancers positive for c-erbB-2 (45%), EGFR (20%), p53 (58%), MiB1 (40%), NCRC11 (78%), were similar to reports for female breast cancer. Nonsignificant associations between pool survival outcome and grade 3 tumours, and positive tissue staining for MiB1 and p53 were seen. Conclusions. While there are similarities in the biological features of breast cancel in males and females, some differences were identified Male breast cancer is more likely to be grade 3 tumours and hormone receptor positive.
引用
收藏
页码:2335 / 2338
页数:4
相关论文
共 50 条
  • [31] Mutivariate Clinic-Pathological Features Analysis for Detecting Unfavorable Independent Prognostic Parameters in Male Breast Cancer
    Stolnicu, Simona
    Dema, Alis
    Boros, Monica
    Moldovan, Cosmin
    Moncea, Denisa
    Barsan, Lulia
    Georgescu, Rares
    Toganel, Cornelia
    Alvarado-Cabrero, Isabel
    LABORATORY INVESTIGATION, 2015, 95 : 68A - 68A
  • [32] Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients
    Dogan, Izzet
    Aydin, Esra
    Yazici, Huelya
    Saip, Pinar
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (04) : 323 - 328
  • [33] Mutivariate Clinic-Pathological Features Analysis for Detecting Unfavorable Independent Prognostic Parameters in Male Breast Cancer
    Stolnicu, Simona
    Dema, Alis
    Boros, Monica
    Moldovan, Cosmin
    Moncea, Denisa
    Barsan, Iulia
    Georgescu, Rares
    Toganel, Cornelia
    Alvarado-Cabrero, Isabel
    MODERN PATHOLOGY, 2015, 28 : 68A - 68A
  • [34] Breast cancer in young women: morphologic features and immunohistochemical status
    Aicha, B.
    Ahlem, L.
    Alia, K.
    Saadia, B.
    Carole, B.
    Olfa, E.
    Sabah, M.
    VIRCHOWS ARCHIV, 2009, 455 : 106 - 106
  • [35] Pregnancy-associated breast cancer: clinicopathologic and immunohistochemical features
    Fujita, T.
    Sakuragi, M.
    Miyazaki, C.
    Shiba, S.
    Sasaki, Y.
    Nishida, S.
    Matsumiya, M.
    BREAST, 2019, 44 : S132 - S133
  • [36] TRIPLE-NEGATIVE BREAST CANCER: CYTOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES
    Nakajima, H.
    Inoue, A.
    Fujita, M.
    Kawabata, K.
    ACTA CYTOLOGICA, 2010, 54 (03) : 437 - 437
  • [37] Clinical and imaging features of male breast disease, with pathological correlation: A pictorial essay
    Ng, Angeline Mei Lian
    Dissanayake, Deepthi
    Metcalf, Cecily
    Wylie, Elizabeth
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (02) : 189 - 198
  • [38] Morphological and pathological features of basal-like breast cancer
    Botti, Gerardo
    Cantile, Monica
    Collina, Francesca
    Cerrone, Margherita
    Sarno, Sabrina
    Anniciello, Annamaria
    Di Bonito, Maurizio
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S503 - S509
  • [39] Pathological features and prognosis of different molecular subtypes of breast cancer
    Wang, Guo-Sheng
    Zhu, Hong
    Bi, Shi-Jie
    MOLECULAR MEDICINE REPORTS, 2012, 6 (04) : 779 - 782
  • [40] Clinical and pathological features of breast cancer with 'polysomy' of Chromosome 17
    Sun, H.
    Chen, H.
    Lim, B.
    Sahin, A. A.
    CANCER RESEARCH, 2019, 79 (04)